Pharmacokinetic profile in special populations
2x AUC in older age population vs young (females > males)
2x AUC in patients with moderate hepatic impairment
Increase in AUC in black population and low weight individuals
- None of these changes are sufficient to require dosage alteration and plasma levels are well within the margin to retain COX-2 specificity